文献速递慢性静脉疾病

年龄并非静脉曲张手术良好结局的障碍

Age is not a barrier to good outcomes after varicose vein procedures.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2017-01-01

基于VQI静脉曲张注册数据库2015年1月至2016年5月4841例手术的前瞻性分析,比较<65岁与≥65岁患者。两组CEAP分级、VCSS和患者报告结局均显著改善,总体并发症无差异;年轻组患者报告结局改善更明显。≥65岁患者应受益于静脉曲张手术,不应仅因年龄被拒绝干预。

要点

  • ≥65岁与<65岁患者静脉曲张术后CEAP分级和VCSS均显著改善。
  • 两组总体并发症无差异,年龄不应作为拒绝手术的唯一依据。
  • 年轻组患者报告结局改善更明显,但老年组仍显著获益。

核心结论

  • ≥65岁患者静脉曲张术后临床结局和患者报告结局均显著改善。
  • 两年龄组CEAP分级和VCSS改善无显著差异,总体并发症无差异。
  • 不应仅因年龄拒绝≥65岁患者的静脉曲张干预。

研究设计与样本

  • 基于VQI静脉曲张注册数据库的前瞻性数据分析。
  • 纳入2015年1月至2016年5月共4841例静脉曲张手术。
  • <65岁组3441例手术(2691例患者,3631条肢体)。
  • ≥65岁组1400例手术(1068例患者,1467条肢体)。

主要发现

  • 两组均以单纯主干静脉治疗最常见,多数为白人和女性。
  • <65岁组BMI更高,≥65岁组双侧静脉曲张治疗史和抗凝更常见。
  • 两组VCSS、患者报告结局和CEAP分级均显著改善。
  • 两组总体并发症无差异,年轻组患者报告结局改善更明显。

关键数值与推荐

  • 比较术前术后CEAP分级、VCSS和患者报告结局(沉重感、酸痛、搏动感、肿胀、瘙痒、外观、对工作影响)。
  • 采用t检验分析各组CEAP分级、VCSS和患者报告结局的变化。

临床怎么用

  • ≥65岁静脉曲张患者可从手术中显著获益,不应仅因年龄拒绝干预。
  • 评估老年患者时应关注整体临床结局和患者报告结局的改善。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Vascular Quality Initiative (VQI) Varicose Vein Registry (VVR) represents a patient-centered database launched in January 2015. Previous work describing overall trends and outcomes of varicose vein procedures across the United States demonstrates a benefit from these procedures. The existing gaps in evidence to support current and future Medicare coverage of varicose vein procedures necessitate further description of clinical outcomes in patients ≥65 years old compared with the population <65 years old. METHODS: This study analyzed prospectively captured anatomic, procedural, and outcome data for all patients in a national cohort of all VQI VVR-participating centers. The VQI VVR database was queried for all patients undergoing varicose vein procedures between January 2015 and July 2016. Preprocedural and postprocedural Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) classification, Venous Clinical Severity Score (VCSS), and patient-reported outcomes (PROs) were compared between patients <65 years and ≥65 years old. Univariate descriptive statistics of demographic and procedural data were performed. Student t-tests were then performed on change in CEAP classification, VCSS score, and PROs (heaviness, achiness, throbbing, swelling, itching, appearance, and impact on work) for each group. RESULTS: There were 4841 varicose vein procedures performed from January 2015 to May 2016. There were 3441 procedures performed in 2691 patients (3631 limbs) in the group <65 years old and 1400 procedures performed in 1068 patients (1467 limbs) in the group ≥65 years old. Truncal veins alone were the most common veins treated in both groups. The majority of patients were white and female in both groups. Most of the demographic characteristics were clinically similar (although statistically different) in both groups with the exception of a higher body mass index in the group <65 years old and a history of bilateral varicose vein treatment, and anticoagulation was more common among patients ≥65 years old. Patients in both groups experienced statistically significant improvement in VCSS, PROs, and CEAP class. There was no difference in overall complications between age groups. CONCLUSIONS: All patients demonstrated an associated improvement in both clinical outcomes (CEAP class, VCSS) and PROs. There was no significant difference in the improvement in CEAP class and VCSS between patients younger and older than 65 years, although the younger population reported greater improvement in PROs. Given these findings, patients older than 65 years appear to benefit from varicose vein procedures and should not be denied interventions on their varicose veins and venous insufficiency on the basis of their age only.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Sutzko DC, Andraska EA, Obi AT, et al. Age is not a barrier to good outcomes after varicose vein procedures. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818215. doi:10.1016/j.jvsv.2017.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。